Tet2 Gene | List of Frontiers open access articles

Original Research

Published on 07 Jun 2019

The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities

in Epigenomics and Epigenetics

Hong Lou
Hongchuan Li
Kevin J. Ho
Luke L. Cai
Andy S. Huang
Tyler R. Shank
Michael R. Verneris
Michael L. Nickerson
Michael Dean
Stephen K. Anderson

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2019.00099

9,267 views
16 citations

Brief Research Report

Published on 22 Aug 2025

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

in Molecular and Cellular Oncology

Yang Zhang
Yujiao Luo
Hongling Peng
Yafei Yin
Guangsen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605369

1,360 views

Original Research

Published on 26 Nov 2021

Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma

in Epigenomics and Epigenetics

Esther K. Elliott
Lloyd N. Hopkins
Robert Hensen
Heidi G. Sutherland
Larisa M. Haupt
Lyn R. Griffiths

Frontiers in Genetics

doi 10.3389/fgene.2021.768913

4,169 views
9 citations

Correction

Published on 10 Dec 2025

Correction: TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models

in Cancer Endocrinology

Yutong Wang
Ailing Yu
Ziping Gao
Xiaoying Yuan
Xiaochen Du
Peng Shi
Haoyun Guan
Shuang Wen
Honglong Wang
Liang Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1738698

675 views

Review

Published on 15 Oct 2025

Unravelling the role of TET2 in venous thromboembolism: insights into mechanisms and therapeutic implications

in Thrombosis and Haemostasis

Yujie Bai
Xiao Wang
Ning Lin
Rongyuan Li
Weilin Hu
Jiayu Wang
Chun Chen
Jie Liu
Jian Feng
Fuxiang Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1577303

1,917 views

Original Research

Published on 14 Apr 2025

TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models

in Cancer Endocrinology

Yutong Wang
Ailing Yu
Ziping Gao
Xiaoying Yuan
Xiaochen Du
Peng Shi
Haoyun Guan
Shuang Wen
Honglong Wang
Liang Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1568665

3,590 views

Original Research

Published on 12 Mar 2021

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study

in Hematologic Malignancies

Daniele Cattaneo
Giorgio Alberto Croci
Cristina Bucelli
Silvia Tabano
Marta Giulia Cannone
Gabriella Gaudioso
Maria Chiara Barbanti
Kordelia Barbullushi
Paola Bianchi
Elisa Fermo

Frontiers in Oncology

doi 10.3389/fonc.2021.637116

27,946 views
30 citations

Original Research

Published on 11 Apr 2022

Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism

in Gynecological Oncology

Jingbo Zhang
Lei Kuang
Yanyu Li
Qing Wang
Hui Xu
Jianwei Liu
Xueyan Zhou
Yang Li
Bei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.856707

4,398 views
9 citations

Articles

The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma

Correction: TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models

Unravelling the role of TET2 in venous thromboembolism: insights into mechanisms and therapeutic implications

TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study

Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism